TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer.

Nicholas D JamesWenyu LiuSarah J PirrieBaljit KaurCarey HendronDaniel FordAnjali ZarkarRichard VineyElizabeth SouthgateAmisha DesaiSyed A Hussainnull null

Published in: BJU international (2022)

Phase I data demonstrate it is feasible and safe to add cetuximab to chemoradiotherapy. Exploratory analysis of phase II data provides evidence to consider further clinical evaluation of cetuximab in this setting.

Keyphrases

phase ii
locally advanced
rectal cancer
clinical trial
muscle invasive bladder cancer
open label
metastatic colorectal cancer
squamous cell carcinoma
phase iii
electronic health record
radiation therapy
wild type
big data
placebo controlled
double blind
data analysis
artificial intelligence